The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Result of the feasibility study of lidocaine (LDC) for peripheral venous pain induced by oxaliplatin (L-OHP).
 
Daisuke Sakai
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Miwako Uemori
No Relationships to Disclose
 
Takashi Sugiura
No Relationships to Disclose
 
Toshihiro Kudo
Honoraria - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma; Lilly; Ono Pharmaceutical; Yakult Honsha
 
Miwa Boku
No Relationships to Disclose
 
Keiko Tanizaki
No Relationships to Disclose
 
Aya Kato
No Relationships to Disclose
 
Tsunekazu Mizushima
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose
 
Masaki Mori
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)
 
Taro Hayashi
No Relationships to Disclose